Form4insider filings, from the source

SEC Form 4 · accession 0001127602-17-027540

LEXICON PHARMACEUTICALS, INC. · LXRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Lonnel Coats
Officer — President and CEO · Director
Period of report
Sep 15, 2017
Accepted (ET)
Sep 18, 2017 · 6:40 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001062822

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Sep 15, 2017P300$12.4866A3,285D
Common StockF1Sep 15, 2017P300$12.485A3,585D
Common StockF1Sep 15, 2017P3,300$12.52A6,885D
Common StockF1Sep 15, 2017P5,200$12.54A12,085D
Common StockF1Sep 15, 2017P3,247$12.5366A15,332D
Common StockF1Sep 15, 2017P4,253$12.53A19,585D
Common StockF1Sep 15, 2017P400$12.535A19,985D
Common StockF1Sep 15, 2017P2,400$12.55A22,385D
Common StockF1Sep 15, 2017P1,951$12.56A24,336D
Common StockF1Sep 15, 2017P2,000$12.57A26,336D
Common StockF1Sep 15, 2017P600$12.5166A26,936D
Common StockF1Sep 15, 2017P300$12.5498A27,236D
Common StockF1Sep 15, 2017P1,200$12.5766A28,436D
Common StockF1Sep 15, 2017P149$12.5662A28,585D
Common StockF1Sep 15, 2017P194$12.51A28,779D
Common StockF1Sep 15, 2017P400$12.5162A29,179D
Common StockF1Sep 15, 2017P100$12.515A29,279D
Common StockF1Sep 15, 2017P1,200$12.519A30,479D
Common StockF1Sep 15, 2017P306$12.537A30,785D
Common StockF1Sep 15, 2017P300$12.5761A31,085D
Common StockF1Sep 15, 2017P300$12.6466A31,385D
Common StockF1Sep 15, 2017P600$12.6166A31,985D
Common StockF1Sep 15, 2017P300$12.6161A32,285D
Common StockF1Sep 15, 2017P300$12.6232A32,585D
Common StockF1Sep 15, 2017P400$12.6361A32,985D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses